Tag: clinical trials
-
Trial Shows Antibiotic More Effective Against Crohn’s Disease
Early results from a clinical trial show an experimental antibiotic drug helps more people achieve remission of their Crohn’s disease for longer periods than a similar group given a placebo.
-
Technique Assessed for Comparing Effectiveness Between Drugs
An academic-industry research team validated a statistical technique to evaluate the effectiveness of different drugs treating the same disease, without conducting separate head-to-head clinical trials.
-
Experimental Drug Extends Survival, Reverses Inherited ALS Damage
An experimental drug designed to silence a protein associated with inherited forms of amyotrophic lateral sclerosis, or ALS, is shown in tests with lab rodents to extend survival and reverse some neuromuscular damage.
-
GSK, 23andMe Ink Precision Meds Discovery Deal
Consumer genetics company 23andMe signed a 4-year agreement to help drug maker GlaxoSmithKline find more precise drug targets and recruit clinical trial participants likely to respond to treatments.
-
Wearables, Game App Help Boost Exercise Levels
A study assessing FitBit devices and a game-style mobile app shows a combination of the technologies results in more exercise by office workers, at least at the outset, than just the FitBit alone.
-
Trial Testing Vitamin D, Fatty Acids for Type 1 Diabetes
A clinical trial is underway testing vitamin D and omega-3 fatty acids in children and adults as a treatment for type 1 diabetes, the form of diabetes where the body does not produce insulin.
-
FDA Issues Draft Gene Therapy Regulatory Guidance
FDA issued a series of draft documents spelling out its processes for reviewing gene therapies for three types of diseases, as well as producing and testing these treatments.
-
Engineered Polio Virus Tested as Brain Cancer Treatment
Results of a clinical trial show a genetically engineered polio virus helps more people with glioblastoma, an aggressive form of brain cancer, survive for longer periods.
-
Cannabis Drug Approved by FDA for Rare, Severe Seizures
A drug based on chemicals derived from cannabis plants was approved by Food and Drug Administration for marketing in the U.S. to treat seizures associated with two rare and severe forms of epilepsy.
-
Cancer T-Cell Start-Up Gains $150 Million in IPO
A three year-old company developing treatments for cancer with engineered T-cells from the immune system raised $150 million in its initial public offering of common stock.